Maxtreme Pharma Limited - Company Profile

It is a chemicals public limited company based in Mumbai, Maharashtra, India, established in 2015.
2015 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Maxtreme Pharma Limited

Maxtreme Pharma Limited, a active public limited company, was established on 03 September 2015 in Mumbai, Maharashtra, India. Engaging in medicinal chemical & botanical products within the manufacturing sector, it holds CIN: U51501MH2015PLC268068. Registered under ROC Roc Mumbai I. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Gaurav Chawla (Director), Sanjeev Kumar (Director), Gulzar Singh (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at B 1908, Mit Niketan, 90 Feet Road, Thakur Complex, Kandivali East, Mumbai, Maharashtra, 400101.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51501MH2015PLC268068

  • Registration Number

    268068

  • Incorporation Date

    03 September 2015

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 10 Year, 9 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth **** %
  • Profit Growth **** -49.14%
  • Ebitda **** -49.14%
  • Net Worth -1069.95%
  • Total Assets -83.93%
Company report

Maxtreme Pharma Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Maxtreme Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Maxtreme Pharma Limited?
Current Directors
Name Designation Appointment Date Status
Gaurav Chawla Director 03 Sep 2015 Current
Sanjeev Kumar Director 03 Sep 2015 Current
Gulzar Singh Director 03 Sep 2015 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Maxtreme Pharma.

Maxtreme Pharma Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 49.14% decrease in profit. The company's net worth observed a substantial decline by a decrease of 1069.95%.

Maxtreme Pharma revenue growth over time
Maxtreme Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -83.93%
*******
*******
*******
*******
Profit or Loss
*******
 -49.14%
*******
*******
*******
*******
Net Worth
*******
 -1069.95%
*******
*******
*******
*******
EBITDA
*******
 -49.14%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Maxtreme Pharma?

In 2019, Maxtreme Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Maxtreme Pharma?

Unlock and access historical data on people associated with Maxtreme Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Maxtreme Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maxtreme Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Maxtreme Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Maxtreme Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Maxtreme Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai I. was completed.

  • Director Appointment

    Gaurav Chawla was appointed as a Director was appointed as a Director on 03 Sep 2015 & has been associated with this company since 10 years 9 months . was recorded as a recent event.

  • Director Appointment

    The activity Sanjeev Kumar was appointed as a Director was appointed as a Director on 03 Sep 2015 & has been associated with this company since 10 years 9 months . was completed.

  • Director Appointment

    The activity Gulzar Singh was appointed as a Director was appointed as a Director on 03 Sep 2015 & has been associated with this company since 10 years 9 months . was completed.

  • Company Incorporation

    The activity Maxtreme Pharma Limited was registered on 03 Sep 2015 with Roc Mumbai I & aged 10 years 9 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Maxtreme Pharma Limited?

The CIN of Maxtreme Pharma Limited is U51501MH2015PLC268068.

Where is Maxtreme Pharma Limited headquartered?

Maxtreme Pharma Limited is headquartered at B 1908, Mit Niketan, 90 Feet Road, Thakur Complex, Kandivali East, Mumbai, Maharashtra, 400101.

When was Maxtreme Pharma Limited incorporated?

Maxtreme Pharma Limited was incorporated on 03 September 2015.

Who are the current directors of Maxtreme Pharma Limited?

The current directors of Maxtreme Pharma Limited are

What is the primary industry of Maxtreme Pharma Limited?

The primary industry of Maxtreme Pharma Limited is Manufacturing.

Is Maxtreme Pharma Limited a listed company?

Maxtreme Pharma Limited is unlisted.

What is the capital structure of Maxtreme Pharma Limited?

The authorized capital of Maxtreme Pharma Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Maxtreme Pharma Limited?

The compliance status of Maxtreme Pharma Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available